Novo Nordisk A/S
CSE:NOVO B
Novo Nordisk A/S
CSE:NOVO B
Price:
928 DKK
-0.09%
Updated:
May 27, 2024
Novo Nordisk A/S
Other Receivables
|
Novo Nordisk A/S
Other Receivables Peer Comparison
Comparables:
HLUN A
ALK B
Competitive Other Receivables Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Other Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Novo Nordisk A/S
CSE:NOVO B
|
Other Receivables
kr14.8B
|
CAGR 3-Years
36%
|
CAGR 5-Years
24%
|
CAGR 10-Years
7%
|
|
|
H Lundbeck A/S
CSE:HLUN A
|
Other Receivables
kr661m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
ALK-Abello A/S
CSE:ALK B
|
Other Receivables
kr108m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
N/A
|
See Also
What is Novo Nordisk A/S's Other Receivables?
Other Receivables
14.8B
DKK
14.8B
DKK
Based on the financial report for Mar 31, 2024, Novo Nordisk A/S's Other Receivables amounts to 14.8B DKK.
What is Novo Nordisk A/S's Other Receivables growth rate?
Other Receivables CAGR 10Y
7%
7%
Over the last year, the Other Receivables growth was 99%. The average annual Other Receivables growth rates for Novo Nordisk A/S have been 36% over the past three years , 24% over the past five years , and 7% over the past ten years .
You don't have any saved screeners yet
